Skip to main content
Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (SHA:600671)
China flag China · Delayed Price · Currency is CNY
21.76
+0.25 (1.16%)
Mar 10, 2026, 2:14 PM CST

SHA:600671 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Mar '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
2,6191,0691,4201,1581,0941,049
Upgrade
Market Cap Growth
119.27%-24.70%22.61%5.90%4.30%-30.11%
Upgrade
Enterprise Value
2,8091,1741,4511,2621,1781,191
Upgrade
Last Close Price
21.518.7811.669.518.988.61
Upgrade
PE Ratio
78.9170.13----
Upgrade
PS Ratio
10.414.9211.6610.637.445.07
Upgrade
PB Ratio
27.7812.5825.38254.0216.9411.23
Upgrade
P/TBV Ratio
43.7323.4147.77-30.0917.04
Upgrade
EV/Sales Ratio
11.175.4011.9211.598.015.76
Upgrade
EV/EBITDA Ratio
44.8928.44----
Upgrade
EV/EBIT Ratio
64.6239.88----
Upgrade
EV/FCF Ratio
-44.23-----
Upgrade
Debt / Equity Ratio
1.841.792.0525.451.761.22
Upgrade
Debt / EBITDA Ratio
2.773.17----
Upgrade
Net Debt / Equity Ratio
1.721.020.3016.161.421.13
Upgrade
Net Debt / EBITDA Ratio
2.902.10-1.47-2.54-4.67-16.39
Upgrade
Net Debt / FCF Ratio
-2.55-1.51-0.57-3.22-2.94-5.23
Upgrade
Asset Turnover
0.630.550.380.310.350.43
Upgrade
Inventory Turnover
2.962.452.171.881.782.11
Upgrade
Quick Ratio
0.610.580.620.340.510.59
Upgrade
Current Ratio
0.810.780.820.560.740.89
Upgrade
Return on Equity (ROE)
43.94%31.02%-129.89%-211.59%-41.52%-45.49%
Upgrade
Return on Assets (ROA)
6.83%4.67%-4.33%-7.78%-4.32%-1.95%
Upgrade
Return on Invested Capital (ROIC)
14.26%18.13%-29.84%-37.48%-16.44%-7.46%
Upgrade
Return on Capital Employed (ROCE)
27.80%19.00%-17.90%-54.00%-19.30%-7.90%
Upgrade
Earnings Yield
1.27%1.43%-2.70%-5.83%-2.73%-3.86%
Upgrade
FCF Yield
-2.42%-5.35%-2.07%-1.98%-2.85%-1.93%
Upgrade
Payout Ratio
28.83%56.30%----
Upgrade
Buyback Yield / Dilution
0.26%0.01%0.00%1.92%-1.13%-0.83%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.